MaxWell Biosystems
PrivateLast Round
Debt
Dec 10, 2021
Total Funding Raised
$4.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MaxWell Biosystems operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Debt round in December 2021.
MaxWell Biosystems is a discovery tools company that provides high-content electrophysiology platforms to advance scientific discovery and accelerate drug discovery for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MaxWell Biosystems Comparables
Compare MaxWell Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3Brain AG | 93% | |
| Axion BioSystems | 88% | |
| Senscell Biosystems | 84% |
For institutional investors. Book with your work email.
MaxWell Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 10, 2021 | ||||
| Series A | Dec 16, 2020 | ||||
| Accelerator | May 23, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MaxWell Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Added Physio-Tech Co., Ltd. as a customer in Medical Equipment Distribution.
- Dec 10, 2021
Secured debt financing from Swiss Technology Fund.
For institutional investors. Book with your work email.
MaxWell Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MaxWell Biosystems's valuation, stock price, and market status.
Is MaxWell Biosystems a public or private company?
MaxWell Biosystems is a private company.
What is the current stock price of MaxWell Biosystems?
MaxWell Biosystems is a private company, so its shares have no public market price. Caplight tracks MaxWell Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MaxWell Biosystems worth (valuation)?
Valuation information for MaxWell Biosystems is not publicly available.
Can I buy MaxWell Biosystems stock?
MaxWell Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MaxWell Biosystems's last funding round?
MaxWell Biosystems's most recent funding round was Debt on December 10, 2021.
Who are the main investors in MaxWell Biosystems?
Key investors in MaxWell Biosystems include Venture Kick.
Will MaxWell Biosystems IPO soon?
No public IPO plans have been announced for MaxWell Biosystems.
How can I track MaxWell Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in MaxWell Biosystems's shares on secondary markets.